The first consensus on diagnosing and managing pseudohypoparathyroidism was published in 2018 after agreed-upon experts were invited from several countries worldwide.

PHP type 1 is further divided into several subtypes a,b, and c. PHP type 1b is isolated resistance to PTH in the kidney and normal PTH response in bone without phenotypic expression of Albright hereditary osteodystrophy (AHO). Novel defects are described in a recent study, and more information is being revealed as we have a better analysis of the genome in recent years.

PHP type 1a has reduced Gs alpha activity and presents with multi-hormone resistance.

PHP type 1c, much like 1a, presents with multi-hormone resistance, but it is different from type 1a in that normal Gs alpha activity is present.